Enantis
PrivateLast Round
Grant
Jul 1, 2024
Total Funding Raised
$3.26M
Momentum
Top 50%
of companies Caplight tracks
Company Overview
Enantis operates in Healthcare & Life Sciences and is based in Brno. Its latest recorded funding round was a Grant round in July 2024.
Enantis is a biotechnology company that develops and manufactures thermostable proteins and provides protein engineering services for therapeutic, cosmetic, and cultured meat applications.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Fashion & Beauty
Business Model
B2B
Customer Profile
Services & Consulting, Data as a Service, Usage-Based SaaS, Government Contracts
AI Layer
Application
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Enantis Comparables
Compare Enantis with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| ORF Genetics | 81% | |
| Core Biogenesis | 79% | |
| Levprot Bioscience | 78% |
For institutional investors. Book with your work email.
Enantis Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Grant | Jul 1, 2024 | ||||
| Grant | Apr 18, 2024 | ||||
| Grant | Jan 1, 2020 | ||||
| VC Round | Dec 31, 2019 | ||||
| Grant | Jun 1, 2016 | ||||
Grant | Sep 1, 2015 |
For institutional investors. Book with your work email.
Key People
Founding team and executive leadership
For institutional investors. Book with your work email.
Enantis Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| New Incubation Ventures | Grant |
| European Commission | Grant |
| Y Soft Ventures | VC Round |
| European Regional Development Fund | Grant |
| Technology Agency of the Czech Republic | Grant |
Market signals
Structured signals derived from secondary market and firmographic data.
- Aug 21, 2026
Monthly visitors increased 796% MoM, reaching 233.
- Mar 1, 2026
Monthly visitors grew 82% MoM.
For institutional investors. Book with your work email.
Enantis Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about Enantis's valuation, stock price, and market status.
Is Enantis a public or private company?
Enantis is a private company.
What is the current stock price of Enantis?
Enantis is a private company, so its shares have no public market price. Caplight tracks Enantis's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Enantis worth (valuation)?
Valuation information for Enantis is not publicly available.
Can I buy Enantis stock?
Enantis shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Enantis's last funding round?
Enantis's most recent funding round was Grant on July 1, 2024.
Who are the main investors in Enantis?
Key investors in Enantis include European Commission, Y Soft Ventures, Technology Agency of the Czech Republic.
Will Enantis IPO soon?
No public IPO plans have been announced for Enantis.
How can I track Enantis secondary market activity?
Caplight tracks bids, offers, and trades in Enantis's shares on secondary markets.